10-QX-Ray Apparatus & Tubes & Related Irradiation Apparatus

GE HEALTHCARE TECHNOLOGIES INC.

GEHC · Period ending 2026-06-30 · Filed 2026-07-29

Valuation

X-Ray Apparatus & Tubes & Related Irradiation Apparatus
Live · Yahoo Finance

Price

$63.93

52-Week Range

$58.75$63.93 now$89.77

Decision Context

Scores are balanced across the six engines. No single dimension dominates — this is consistent with a stable, mid-tier quality business.

Based on filing period ending Jun 2026

FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.

GEHC vs

Macro Context

Fed Funds Rate

3.63%

Accommodative

10-Year Treasury

4.60%

2026-07-01

Unemployment

4.1%

Near full employment

CPI Index

332.8

2026-07-01

M2 Money Supply

$23.2T

2026-06-01

The Federal Funds rate stands at 3.63% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 4.60%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.1%; Industrial production index is at 102.6; M2 money supply is $23.2T; CPI index stands at 332.8.

SWOT Analysis — GEHC

Inflationary Boom

Strengths

  • Total Assets: $36.9B (+11.5% YoY) — Total assets grew 12% — the company's resource base expanded.

Weaknesses

No material weaknesses flagged.

Opportunities

  • Revenue: $20.6B (+4.8% YoY) — Revenue grew 5% — the company sold more goods or services than the prior year.

  • EPS (Diluted): $4.55 (+4.8% YoY) — Earnings per share rose 5% — each share earned more.

  • Net Income: $2.1B (+4.6% YoY) — Profit grew 5% — the company kept more of each dollar earned.

  • Operating Cash Flow: $2.0B (+1.6% YoY) — Operating cash flow grew 2% — the business generated more cash from day-to-day operations.

Threats

No significant threats flagged.

Financial Charts

Revenue vs Net Income

Gross Profit vs Operating Income

Margin Trend

Year-over-Year Changes

Total Assets

$36.9B

was $33.1B

+11.5%

Total assets grew 12% — the company's resource base expanded.

Revenue

$20.6B

was $19.7B

+4.8%

Revenue grew 5% — the company sold more goods or services than the prior year.

EPS (Diluted)

$4.55

was $4.34

+4.8%

Earnings per share rose 5% — each share earned more.

Net Income

$2.1B

was $2.0B

+4.6%

Profit grew 5% — the company kept more of each dollar earned.

Operating Cash Flow

$2.0B

was $2.0B

+1.6%

Operating cash flow grew 2% — the business generated more cash from day-to-day operations.

Price History

Technical Signals

Daily closes · 1-year data

Latest News

via Finnhub

Filing History — GEHC

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Trade GEHC

Links open broker research pages. Not an endorsement or recommendation.

Research GE HEALTHCARE TECHNOLOGIES INC.

Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.